Indivior PLC INDV-GB:London Stock Exchange

RT Quote | Exchange | GBp
Last | 05/01/24 BST
1,428.00UNCH (UNCH)
52 week range
1,125.00 - 1,938.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1,428.00
  • 52 Week High1,938.00
  • 52 Week High Date07/24/23
  • 52 Week Low1,125.00
  • 52 Week Low Date12/19/23

Key Stats

  • Market Cap2,395.2M
  • Shares Out135.41M
  • 10 Day Average Volume596,785.7
  • Dividend-
  • Dividend Yield-
  • Beta0.65
  • YTD % Change20.51

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1,428.00
  • 52 Week High1,938.00
  • 52 Week High Date07/24/23
  • 52 Week Low1,125.00
  • 52 Week Low Date12/19/23
  • Market Cap2,395.2M
  • Shares Out135.41M
  • 10 Day Average Volume596,785.7
  • Dividend-
  • Dividend Yield-
  • Beta0.65
  • YTD % Change20.51

RATIOS/PROFITABILITY

  • EPS (TTM)3.13
  • P/E (TTM)456.23
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date06/16/2016
  • Div Amount7.30
  • Split Date-
  • Split Factor-

Latest On Indivior PLC

 

Profile

MORE
Indivior PLC is a pharmaceutical company. The Company develops medicines to treat addiction and serious mental illnesses. The Company focuses on building a portfolio of opioid dependence treatments. It has a pipeline of product candidates designed to address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder. Its product pipeline focuses on development and discovery of non-opioid treatment strategies for opioid use disorder (OUD)...
Graham Hetherington
Non-Executive Chairman of the Board
Mark Crossley
Chief Executive Officer, Executive Director
Ryan Preblick
Chief Financial Officer, Executive Director
Address
10710 Midlothian Turnpike
Suite 125, North Chesterfield
Chesterfield, VA
23235
United States